Cargando…
Integrating Immunotherapy into Multimodal Treatment of Head and Neck Cancer
SIMPLE SUMMARY: Immune checkpoint inhibitors have become the standard of care therapy in a multimodal setting for recurrent/metastatic HNSCC. Multiple clinical trials have recently looked at the addition of ICI to multimodal treatments in locally advanced HNSCC. Multiple Phase II/III trials are inve...
Autores principales: | Rao, Yuan James, Goodman, Joseph F., Haroun, Faysal, Bauman, Julie E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913370/ https://www.ncbi.nlm.nih.gov/pubmed/36765627 http://dx.doi.org/10.3390/cancers15030672 |
Ejemplares similares
-
Immunotherapy Approaches in HPV-Associated Head and Neck Cancer
por: Julian, Ricklie, et al.
Publicado: (2021) -
Multimodality imaging of head and neck cancer
por: King, A.D.
Publicado: (2007) -
Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer
por: Jones, Trace M., et al.
Publicado: (2021) -
Combining Radiotherapy and Immunotherapy in Head and Neck Cancer
por: Runnels, Juliana, et al.
Publicado: (2023) -
Precision and Immunoprevention Strategies for Tobacco-Related Head and Neck Cancer Chemoprevention
por: Centuori, Sara M., et al.
Publicado: (2021)